These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 14696119)
1. Recombinant single-chain antibody fusion construct targeting human melanoma cells and containing tumor necrosis factor. Liu Y; Cheung LH; Marks JW; Rosenblum MG Int J Cancer; 2004 Feb; 108(4):549-57. PubMed ID: 14696119 [TBL] [Abstract][Full Text] [Related]
2. Improved expression of a soluble single chain antibody fusion protein containing tumor necrosis factor in Escherichia coli. Kim S; Cheung LH; Zhang W; Rosenblum MG Appl Microbiol Biotechnol; 2007 Nov; 77(1):99-106. PubMed ID: 17703297 [TBL] [Abstract][Full Text] [Related]
3. The antimelanoma immunocytokine scFvMEL/TNF shows reduced toxicity and potent antitumor activity against human tumor xenografts. Liu Y; Zhang W; Cheung LH; Niu T; Wu Q; Li C; Van Pelt CS; Rosenblum MG Neoplasia; 2006 May; 8(5):384-93. PubMed ID: 16790087 [TBL] [Abstract][Full Text] [Related]
4. Cytotoxic and antitumor activity of a recombinant tumor necrosis factor-B1(Fv) fusion protein on LeY antigen-expressing human cancer cells. Scherf U; Benhar I; Webber KO; Pastan I; Brinkmann U Clin Cancer Res; 1996 Sep; 2(9):1523-31. PubMed ID: 9816329 [TBL] [Abstract][Full Text] [Related]
5. Characterization and mechanistic studies of a novel melanoma-targeting construct containing IκBa for specific inhibition of nuclear factor-κB activity. Zhou H; Liu Y; Cheung LH; Kim S; Zhang W; Mohamedali KA; Anand P; Hittelman WN; Aggarwal BB; Rosenblum MG Neoplasia; 2010 Oct; 12(10):766-77. PubMed ID: 20927315 [TBL] [Abstract][Full Text] [Related]
6. In vivo tumor delivery of a recombinant single chain Fv::tumor necrosis factor-alpha fusion [correction of factor: a fusion] protein. Cooke SP; Pedley RB; Boden R; Begent RH; Chester KA Bioconjug Chem; 2002; 13(1):7-15. PubMed ID: 11792173 [TBL] [Abstract][Full Text] [Related]
7. Multi-modality therapeutics with potent anti-tumor effects: photochemical internalization enhances delivery of the fusion toxin scFvMEL/rGel. Selbo PK; Rosenblum MG; Cheung LH; Zhang W; Berg K PLoS One; 2009 Aug; 4(8):e6691. PubMed ID: 19690617 [TBL] [Abstract][Full Text] [Related]
8. A novel recombinant fusion toxin targeting HER-2/NEU-over-expressing cells and containing human tumor necrosis factor. Rosenblum MG; Horn SA; Cheung LH Int J Cancer; 2000 Oct; 88(2):267-73. PubMed ID: 11004679 [TBL] [Abstract][Full Text] [Related]
10. Targeted delivery of human pro-apoptotic enzymes to tumor cells: In vitro studies describing a novel class of recombinant highly cytotoxic agents. Liu Y; Cheung LH; Hittelman WN; Rosenblum MG Mol Cancer Ther; 2003 Dec; 2(12):1341-50. PubMed ID: 14707275 [TBL] [Abstract][Full Text] [Related]
11. A quantitative analysis of tumor specific monoclonal antibody uptake by human melanoma xenografts: effects of antibody immunological properties and tumor antigen expression levels. Shockley TR; Lin K; Sung C; Nagy JA; Tompkins RG; Dedrick RL; Dvorak HF; Yarmush ML Cancer Res; 1992 Jan; 52(2):357-66. PubMed ID: 1728407 [TBL] [Abstract][Full Text] [Related]
12. Design, expression, purification, and characterization, in vitro and in vivo, of an antimelanoma single-chain Fv antibody fused to the toxin gelonin. Rosenblum MG; Cheung LH; Liu Y; Marks JW Cancer Res; 2003 Jul; 63(14):3995-4002. PubMed ID: 12873997 [TBL] [Abstract][Full Text] [Related]
13. Targeted Delivery of TNF Potentiates the Antibody-Dependent Cell-Mediated Cytotoxicity of an Anti-Melanoma Immunoglobulin. Murer P; Kiefer JD; Plüss L; Matasci M; Blümich SL; Stringhini M; Neri D J Invest Dermatol; 2019 Jun; 139(6):1339-1348. PubMed ID: 30543899 [TBL] [Abstract][Full Text] [Related]
14. Targeted interleukin 2 therapy enhances protective immunity induced by an autologous oral DNA vaccine against murine melanoma. Niethammer AG; Xiang R; Ruehlmann JM; Lode HN; Dolman CS; Gillies SD; Reisfeld RA Cancer Res; 2001 Aug; 61(16):6178-84. PubMed ID: 11507070 [TBL] [Abstract][Full Text] [Related]
15. A genetically engineered single-chain FV/TNF molecule possesses the anti-tumor immunoreactivity of FV as well as the cytotoxic activity of tumor necrosis factor. Yang J; Moyana T; Xiang J Mol Immunol; 1995 Aug; 32(12):873-81. PubMed ID: 7565814 [TBL] [Abstract][Full Text] [Related]